The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

BACKGROUND: Type 2 diabetes (T2D) is associated with reduction and dysfunction of circulating pro-angiogenic cells (PACs). DPP-4 inhibitors, a class of oral agents for T2D, might possess pleiotropic vasculoprotective activities. Herein, we tested whether DPP-4 inhibition with Saxagliptin affects the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Poncina, Nicol, Albiero, Mattia, Menegazzo, Lisa, Cappellari, Roberta, Avogaro, Angelo, Fadini, Gian Paolo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033689/
https://ncbi.nlm.nih.gov/pubmed/24886621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-13-92
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars